Equity Income Fund

Fund overview

The Investors Mutual Equity Income Fund provides exposure to a diversified portfolio of quality ASX listed shares. The Fund aims to provide a regular and relatively high income stream with lower levels of volatility relative to the S&P/ASX 300 Accumulation Index and some capital growth to investors. The Fund applies IML’s conservative value based investment philosophy with a long term focus and aims to deliver consistent returns to clients.



Investors Mutual Equity Income Fund

IML Investment Director Anton Tagliaferro and Senior Equities Analyst Nigel Hale provide an introduction to the IML Equity Income Fund, its investment approach and why its relevant for clients.

Fund Facts

  • Portfolio Managers:
    Anton Tagliaferro, Michael O'Neill & Tuan Luu
  • Benchmark:
    S&P/ASX 300 Accumulation Index
  • Inception:
    1 Jan 2011
  • ARSN:
    107 095 438
  • APIR:
  • Distribution Frequency:
    Generally Quarterly
  • Performance fee:
  • Management fee:
    0.993% p.a. of the net assets of the fund (includes GST).

Investment Objective

The Fund's dual objectives are to provide a dividend yield (after fees and expenses and before taxes) which exceeds a yield of 2% above that of the S&P/ASX 300 Accumulation Index on a rolling four year basis, whilst maintaining lower levels of volatility relative to the S&P/ASX 300 Accumulation index.

Investment Strategy

The Fund will invest in a diversified portfolio of quality high yielding ASX listed Australian and New Zealand shares, hybrids, bought and sold options and cash.

Net Performance

Unit Prices

Distribution Information

Period Ending Distribution
March 2022 1.3 cpu
December 2021 1.4 cpu
September 2021 1.4 cpu
June 2021 1.1 cpu
March 2021 1.3 cpu
December 2020 1.4 cpu
September 2020 1.4 cpu
June 2020 1.9 cpu
March 2020 1.6 cpu
December 2019 1.7 cpu
September 2019 1.8 cpu
June 2019 2.3 cpu
March 2019 1.8 cpu
December 2018 1.9 cpu
September 2018 2.0 cpu
June 2018 2.9 cpu
March 2018 1.8 cpu
December 2017 1.9 cpu
September 2017 1.8 cpu
June 2017 3.6 cpu
March 2017 2.0 cpu
December 2016 1.9 cpu
September 2016 1.0 cpu
June 2016 2.9 cpu
March 2016 1.9 cpu

For more information please refer to our Distributions page

Past performance is not indicative of future performance as a result past distributions are not indicative of future distributions.

Ratings and Awards

Researcher Rating
Morningstar Bronze
Lonsec Contact IML for the most recent rating
Zenith Recommended


mstar bronze        Zenith Recommended

For the most recent research house ratings report please contact your state manager.

© 2022 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice or ‘class service’ have been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. Refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement (Australian products) or Investment Statement (New Zealand products) before making any decision to invest. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782 ("ASXO").
The Zenith Investment Partners (“Zenith”) Australian Financial Services License No. 226872 rating (assigned 24 June 2021) referred to in this document is limited to “General Advice” (as defined by the Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Zenith usually charges the product issuer, fund manager or a related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessment’s and at http://www.zenithpartners.com.au/RegulatoryGuidelines

View more